NEW YORK (GenomeWeb News) – Complete Genomics CEO Clifford Reid has told the firm's employees that its purchase by BGI-Shenzhen is anticipated to be completed during the first quarter of 2013, while disputing suggestions that a merger with the Chinese sequencing services firm poses national security issues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.